BetterLife Pharma Inc. (BETR)
CSE
Closed
Aug 24, 2026
Day's Range
0.295052 wk Range
0.0400Profile - BETR - BetterLife Pharma Inc.
Profile
Mic Code
XCNQ
Sector
Healthcare
Industry
Biotechnology
Employees
0
BetterLife Pharma Inc. is an emerging biotechnology company focused on developing cutting-edge treatments for mental health disorders, primarily through psychedelic compounds. The company's work is centered on harnessing the therapeutic potential of psychedelic derivatives, aiming to address unmet needs in mental health care. By advancing its research and development efforts, BetterLife Pharma Inc. seeks to pioneer new, effective treatment options that could transform approaches to mental health conditions such as depression and anxiety disorders. The company operates within the burgeoning biotech sector, a space characterized by rapid innovation and significant investment in medical and pharmaceutical advancements. Due to its focus on psychedelics—a promising area of research due to recent scientific interest and regulatory shifts—BetterLife Pharma Inc. plays a potentially influential role in the development and commercialization of novel mental health therapies. Through strategic partnerships and maintaining a keen focus on scientific innovation, the company is poised to contribute to the expanding field of mental healthcare solutions.
Profile Details
Type
Common Stock
Ceo
Dr. Ahmad Doroudian Ph.D.
Address
1275 West 6th Avenue
City
Vancouver
State
BC
Zip
V6H 1A6
Country
Canada
Phone
604 221 0595
Key Executives - BETR - BetterLife Pharma Inc.
Key executives
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
